
<!DOCTYPE html>
<html lang="en" dir="ltr" prefix="og: https://ogp.me/ns#">
  
<!-- Mirrored from investors.scholarrock.com/node/9441/html by HTTrack Website Copier/3.x [XR&CO'2014], Sat, 21 Dec 2024 12:08:07 GMT -->
<!-- Added by HTTrack --><meta http-equiv="content-type" content="text/html;charset=UTF-8" /><!-- /Added by HTTrack -->
<head>
    <title>SEC Filing - Scholar Rock, Inc.</title>
    <meta name="robots" content="noindex">
    <link rel="stylesheet" media="all" href="../../sites/g/files/knoqqb56236/files/css/css_-Ogun-b4Vwq8nD6qwBoEYuBhEF_0grnAaUrH4akFvLUcd37.css?delta=0&amp;language=en&amp;theme=nir_pid2662&amp;include=eJyNjEEKgDAMBD8k9UkhTQMGSiJNRfp7ayuePHjK7jAblQIRnVdnAq8tsy_a2cnRpTKoVSH29YOF5w5__LiDkOlEqJhbN-b4bQGTRYaMh9L2Q9yLpQuf0kIl" />

    
    <!-- IrwinIQ Tag Manager --> <script> (function(w,d){ var _mtm = w._mtm = w._mtm || []; _mtm.push({'mtm.startTime': (new Date().getTime()), 'event': 'mtm.Start'}); var g=d.createElement('script'), s=d.getElementsByTagName('script')[0]; g.async=true; g.src='../../../analytics.imirwin.com/js/container_XFyWYf0m.js'; s.parentNode.insertBefore(g,s); })(window, document); </script> <!-- End IrwinIQ Tag Manager -->

<!-- Google Tag Manager -->
<script>(function(w,d,s,l,i){w[l]=w[l]||[];w[l].push({'gtm.start':
new Date().getTime(),event:'gtm.js'});var f=d.getElementsByTagName(s)[0],
j=d.createElement(s),dl=l!='dataLayer'?'&l='+l:'';j.async=true;j.src=
'../../../www.googletagmanager.com/gtm5445.html?id='+i+dl;f.parentNode.insertBefore(j,f);
})(window,document,'script','dataLayer','GTM-WTGMF33');</script>
<!-- End Google Tag Manager -->

<!-- Google Tag Manager (noscript) -->
<noscript><iframe src="../../../www.googletagmanager.com/nsca0c.html?id=GTM-WTGMF33"
height="0" width="0" style="display:none;visibility:hidden"></iframe></noscript>
<!-- End Google Tag Manager (noscript) -->
  
                    <script>var w=window;if(w.performance||w.mozPerformance||w.msPerformance||w.webkitPerformance){var d=document;AKSB=w.AKSB||{},AKSB.q=AKSB.q||[],AKSB.mark=AKSB.mark||function(e,_){AKSB.q.push(["mark",e,_||(new Date).getTime()])},AKSB.measure=AKSB.measure||function(e,_,t){AKSB.q.push(["measure",e,_,t||(new Date).getTime()])},AKSB.done=AKSB.done||function(e){AKSB.q.push(["done",e])},AKSB.mark("firstbyte",(new Date).getTime()),AKSB.prof={custid:"543865",ustr:"",originlat:"0",clientrtt:"426",ghostip:"23.62.181.15",ipv6:false,pct:"10",clientip:"105.119.6.83",requestid:"3791f239",region:"42877",protocol:"",blver:14,akM:"dsca",akN:"ae",akTT:"O",akTX:"1",akTI:"3791f239",ai:"505979",ra:"false",pmgn:"",pmgi:"",pmp:"",qc:""},function(e){var _=d.createElement("script");_.async="async",_.src=e;var t=d.getElementsByTagName("script"),t=t[t.length-1];t.parentNode.insertBefore(_,t)}(("https:"===d.location.protocol?"https:":"http:")+"//ds-aksb-a.akamaihd.net/aksb.min.js")}</script>
                    </head>
  <body class="body-sidebars-first nir-node nir-node--type-nir-sec-filing nir-node--9441 page-template-default page page-parent wp-custom-logo wp-embed-responsive full-width-content genesis-breadcrumbs-visible genesis-singular-image-hidden genesis-footer-widgets-visible top-parent-investors-media investors-media has-no-blocks elementor-default elementor-page cbp-spmenu-push cookies-set cookies-accepted body_classes" id="body" cz-shortcut-listen="true">
      <div class="region region-content">
    <div id="block-nir-pid2662-websitenoticeblock" class="block--website-notice-block block--website-notice-block--9441 block--content--website-notice-block block--content--website-notice-block--9441 block--24a64b1d-13aa-4b20-8029-2df59f99a96c block--24a64b1d-13aa-4b20-8029-2df59f99a96c--9441 block block-nir-website-notices block-website-notice-block">
  
    
      
  </div>
<div data-drupal-messages-fallback class="hidden"></div>

<div id="block-nir-pid2662-content" class="block--system-main-block block--system-main-block--9441 block--content--system-main-block block--content--system-main-block--9441 block--c4d2f333-a7f8-46c4-afc3-3e36992b73c0 block--c4d2f333-a7f8-46c4-afc3-3e36992b73c0--9441 block block-system block-system-main-block">
  
    
      <div class="nir-sec-header"><div class="logo"><img src="../../sites/g/files/knoqqb56236/files/Logo.png" alt="Scholar Rock, Inc." />
</div><div class="sec-docs">View:  <div class="field ixbrl-link">
    <a href="ixbrl-viewer"></a>
  </div>
  <div class="file-link">
  <span class="file file--mime-application-rtf file--general"> <a href="../../static-files/0001157523-23-000777.rtf%3b%20filename_%3dUTF-8%27%270001157523-23-000777.rtf" type="application/rtf" title="0001157523-23-000777.rtf">Download DOC</a></span><span class="filesize"> </span>
</div>
  <div class="file-link">
  <span class="file file--mime-application-pdf file--application-pdf"> <a href="../../static-files/0001157523-23-000777.pdf%3b%20filename_%3dUTF-8%27%270001157523-23-000777.pdf" type="application/pdf" title="0001157523-23-000777.pdf">Download PDF</a></span><span class="filesize"> </span>
</div>
  <div class="file-link">
  <span class="file file--mime-application-vnd-ms-excel file--x-office-spreadsheet"> <a href="../../static-files/0001157523-23-000777.xls%3b%20filename_%3dUTF-8%27%270001157523-23-000777.xls" type="application/vnd.ms-excel" title="0001157523-23-000777.xls">Download XLS</a></span><span class="filesize"> </span>
</div>
  <div class="file-link">
  <span class="file file--mime-application-octet-stream file--general"> <a href="../../sec-filings/sec-filing/8-k/0001157523-23-000777.html" type="application/octet-stream" title="0001157523-23-000777-ex-101-sch---xbrl-taxonomy-extension-schema.xsd">Download XBRL</a></span><span class="filesize"> </span>
</div>
</div></div>
    <XBRL>
<html xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:srt="http://fasb.org/srt/2021-01-31" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:us-gaap="http://fasb.org/us-gaap/2021-01-31" xmlns:dei="http://xbrl.sec.gov/dei/2021" xmlns:country="http://xbrl.sec.gov/country/2021" xmlns:currency="http://xbrl.sec.gov/currency/2021" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:naics="http://xbrl.sec.gov/naics/2021" xmlns:sic="http://xbrl.sec.gov/sic/2021" xmlns:stpr="http://xbrl.sec.gov/stpr/2021" xmlns:exch="http://xbrl.sec.gov/exch/2021" xmlns:srrk="http://scholarrock.com/20230509" xmlns="http://www.w3.org/1999/xhtml">
  <head>
    <title></title>
    <!-- Licensed to: Business Wire
         Document created using Broadridge PROfile 23.3.1.5138
         Copyright 1995 - 2023 Broadridge -->
    <meta http-equiv="Content-Type" content="text/html" />

                    <script>var w=window;if(w.performance||w.mozPerformance||w.msPerformance||w.webkitPerformance){var d=document;AKSB=w.AKSB||{},AKSB.q=AKSB.q||[],AKSB.mark=AKSB.mark||function(e,_){AKSB.q.push(["mark",e,_||(new Date).getTime()])},AKSB.measure=AKSB.measure||function(e,_,t){AKSB.q.push(["measure",e,_,t||(new Date).getTime()])},AKSB.done=AKSB.done||function(e){AKSB.q.push(["done",e])},AKSB.mark("firstbyte",(new Date).getTime()),AKSB.prof={custid:"543865",ustr:"",originlat:"0",clientrtt:"426",ghostip:"23.62.181.15",ipv6:false,pct:"10",clientip:"105.119.6.83",requestid:"3791f239",region:"42877",protocol:"",blver:14,akM:"dsca",akN:"ae",akTT:"O",akTX:"1",akTI:"3791f239",ai:"505979",ra:"false",pmgn:"",pmgi:"",pmp:"",qc:""},function(e){var _=d.createElement("script");_.async="async",_.src=e;var t=d.getElementsByTagName("script"),t=t[t.length-1];t.parentNode.insertBefore(_,t)}(("https:"===d.location.protocol?"https:":"http:")+"//ds-aksb-a.akamaihd.net/aksb.min.js")}</script>
                    </head>

<body style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left; color: #000000; background-color: #ffffff;">
<div id="DSPFiXBRLHidden" style="display: none;"><ix:header><ix:hidden><ix:nonNumeric name="dei:AmendmentFlag" id="Fact_519c1ffdba27485a88e3520e6cbdc84c" contextRef="c20230509to20230509" format="ixt:fixed-false">false</ix:nonNumeric><ix:nonNumeric name="dei:EntityCentralIndexKey" id="Fact_efe5e420d7154287a5b43e5435911680" contextRef="c20230509to20230509">0001727196</ix:nonNumeric></ix:hidden><ix:references><link:schemaRef xlink:href="#srrk-20230509.xsd" xlink:type="simple"></link:schemaRef></ix:references><ix:resources><xbrli:context id="c20230509to20230509"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001727196</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2023-05-09</xbrli:startDate><xbrli:endDate>2023-05-09</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div>

  <div>
    <div>
      <div style="text-align: center;"><span style="font-weight: bold; background-color: rgb(255, 255, 255); color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif; font-size: 16pt; font-style: normal; font-variant: normal; text-transform: none;">UNITED







          STATES<br />
          SECURITIES AND EXCHANGE COMMISSION</span><br />
        <span style="font-weight: bold;">Washington, D.C. 20549</span><br />
        _____________________</div>

      <div>&#160;</div>

      <div style="text-align: center;"><span style="font-weight: bold; background-color: rgb(255, 255, 255); color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif; font-size: 16pt; font-style: normal; font-variant: normal; text-transform: none;">FORM







          <ix:nonNumeric name="dei:DocumentType" id="Fact_9644b0baee814417884b0651e139b463" contextRef="c20230509to20230509">8-K</ix:nonNumeric></span><br />
        _____________________</div>

      <div>&#160;</div>

      <div style="text-align: center; font-weight: bold;">CURRENT REPORT<br />
      </div>

      <div>&#160;</div>

      <div style="text-align: center; font-weight: bold;">Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934</div>

      <div>&#160;</div>

      <div style="text-align: center;">Date of Report (Date of earliest event Reported): <ix:nonNumeric name="dei:DocumentPeriodEndDate" id="Fact_6aab694c1ce94e10b81a0b27e690a159" contextRef="c20230509to20230509" format="ixt:date-monthname-day-year-en">May 9, 2023</ix:nonNumeric></div>

      <div>&#160;</div>

      <div style="text-align: center;"><span style="font-weight: bold; background-color: rgb(255, 255, 255); color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif; font-size: 16pt; font-style: normal; font-variant: normal; text-transform: none;"><ix:nonNumeric name="dei:EntityRegistrantName" id="Fact_2fb50baad7074bd0b3c03f8728f8bbd6" contextRef="c20230509to20230509">Scholar Rock Holding Corp</ix:nonNumeric>oration</span><br />
        (Exact Name of Registrant as Specified in Charter)</div>

      <div>&#160;</div>

      <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">


  <tr>

    <td style="width: 33%; vertical-align: top;">
              <div style="text-align: center; font-weight: bold;"><ix:nonNumeric name="dei:EntityIncorporationStateCountryCode" id="Fact_8d9aaedbd317457eb89abbcd3dd585a0" contextRef="c20230509to20230509" format="ixt-sec:stateprovnameen">Delaware</ix:nonNumeric><br />
              </div>
            </td>

    <td style="width: 34%; vertical-align: top;">
              <div style="text-align: center; font-weight: bold;"><ix:nonNumeric name="dei:EntityFileNumber" id="Fact_5501f45c9cf145f392d1bebeb5c4abf6" contextRef="c20230509to20230509">001-38501</ix:nonNumeric><br />
              </div>
            </td>

    <td style="width: 33%; vertical-align: top;">
              <div style="text-align: center; font-weight: bold;"><ix:nonNumeric name="dei:EntityTaxIdentificationNumber" id="Fact_981a277ce36247b99eb4b029c63a65b7" contextRef="c20230509to20230509">82-3750435</ix:nonNumeric><br />
              </div>
            </td>

  </tr>

  <tr>

    <td style="width: 33%; vertical-align: top;">
              <div style="text-align: center;">(State or Other Jurisdiction of Incorporation)</div>
            </td>

    <td style="width: 34%; vertical-align: top;">
              <div style="text-align: center;">(Commission File Number)</div>
            </td>

    <td style="width: 33%; vertical-align: top;">
              <div style="text-align: center;">(I.R.S. Employer Identification Number)</div>
            </td>

  </tr>


</table>
      <div><br />
      </div>

      <div style="text-align: center;">
        <div style="text-align: center; font-family: 'Times New Roman',Times,serif; font-size: 10pt; font-weight: bold;"> <br />
        </div>

        <div style="text-align: center; font-family: 'Times New Roman',Times,serif; font-size: 10pt; font-weight: bold;"><ix:nonNumeric name="dei:EntityAddressAddressLine1" id="Fact_649ff566fd8043798e5f60cf66ce5a0a" contextRef="c20230509to20230509">301 Binney Street</ix:nonNumeric><span style="font-weight: bold;">, </span><ix:nonNumeric name="dei:EntityAddressAddressLine2" id="Fact_c6efcfcb763e49be80a81302847aa912" contextRef="c20230509to20230509">3rd Floor</ix:nonNumeric><span style="font-weight: bold;">, <ix:nonNumeric name="dei:EntityAddressCityOrTown" id="Fact_212c1335b0fd4646b5c114b9660100d5" contextRef="c20230509to20230509">Cambridge</ix:nonNumeric>, <ix:nonNumeric name="dei:EntityAddressStateOrProvince" id="Fact_3435c8f8bf994636bdf2436de2f17f48" contextRef="c20230509to20230509">MA</ix:nonNumeric> <ix:nonNumeric name="dei:EntityAddressPostalZipCode" id="Fact_387482066fd14fddbcca86523175b435" contextRef="c20230509to20230509">02142</ix:nonNumeric></span></div>
<div>
        (Address of Principal Executive Offices) (Zip Code)</div>
</div>

      <div>&#160;</div>

      <div style="text-align: center;"><span style="font-weight: bold;">(<ix:nonNumeric name="dei:CityAreaCode" id="Fact_f507da56c2614138992ce6dc1cda0c0d" contextRef="c20230509to20230509">857</ix:nonNumeric>) <ix:nonNumeric name="dei:LocalPhoneNumber" id="Fact_861f3809ad2840829698e711a4957541" contextRef="c20230509to20230509">259-3860</ix:nonNumeric></span><br />
        (Registrant&#8217;s telephone number, including area code)</div>

      <div>&#160;</div>

      <div style="text-align: center;">(Former name or former address, if changed since last report)</div>

      <div>&#160;</div>

      <div>Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</div>

      <div>&#160;</div>

      <div style="text-indent: -18pt; margin-left: 36pt;"><ix:nonNumeric name="dei:WrittenCommunications" id="Fact_a23bfa60985d4304a24434161a76a00f" contextRef="c20230509to20230509" format="ixt-sec:boolballotbox">&#x2610;</ix:nonNumeric>&#160;<span style="text-indent: 0px; font-size: 6pt;" class="BRFWTab">&#160; </span>Written
        communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</div>

      <div style="text-indent: -18pt; margin-left: 36pt;"><ix:nonNumeric name="dei:SolicitingMaterial" id="Fact_378877e40df742e3b6cf4f1ee27e77c7" contextRef="c20230509to20230509" format="ixt-sec:boolballotbox">&#x2610;</ix:nonNumeric>&#160;<span style="text-indent: 0px; font-size: 6pt;" class="BRFWTab">&#160; </span>Soliciting
        material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</div>

      <div style="text-indent: -18pt; margin-left: 36pt;"><ix:nonNumeric name="dei:PreCommencementTenderOffer" id="Fact_70380ff8dbe04107bdf0382c9baa3b0e" contextRef="c20230509to20230509" format="ixt-sec:boolballotbox">&#x2610;</ix:nonNumeric>&#160;<span style="text-indent: 0px; font-size: 6pt;" class="BRFWTab">&#160; </span>Pre-commencement








        communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</div>

      <div style="text-indent: -18pt; margin-left: 36pt;"><ix:nonNumeric name="dei:PreCommencementIssuerTenderOffer" id="Fact_9c578dabff6e4df797fcd7f7c77d2818" contextRef="c20230509to20230509" format="ixt-sec:boolballotbox">&#x2610;</ix:nonNumeric>&#160;<span style="text-indent: 0px; font-size: 6pt;" class="BRFWTab">&#160; </span>Pre-commencement








        communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</div>

      <div>&#160;</div>

      <div>Securities registered pursuant to Section 12(b) of the Act:</div>

      <div>&#160;</div>

      <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">


  <tr>

    <td style="width: 39.56%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
              <div style="text-align: center; font-weight: bold;">Title of each class</div>
            </td>

    <td style="width: 22%; vertical-align: top; border-width: 2px; border-style: solid; border-color: rgb(0, 0, 0);">
              <div style="text-align: center; font-weight: bold;">Trading Symbol(s)</div>
            </td>

    <td style="width: 38%; vertical-align: top; border-width: 2px; border-style: solid; border-color: rgb(0, 0, 0);">
              <div style="text-align: center; font-weight: bold;">Name of each exchange on which registered</div>
            </td>

  </tr>

  <tr>

    <td style="width: 39.56%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
              <div style="text-align: center;"><ix:nonNumeric name="dei:Security12bTitle" id="Fact_93610d6461734352b93fcd2210b65bb0" contextRef="c20230509to20230509">Common Stock, par value $0.001 per share</ix:nonNumeric><br />
              </div>
            </td>

    <td style="width: 22%; vertical-align: top; border-width: 2px; border-style: solid; border-color: rgb(0, 0, 0);">
              <div style="text-align: center;"><ix:nonNumeric name="dei:TradingSymbol" id="Fact_3418ad2a79e44a7bbc39f58f5846a4bb" contextRef="c20230509to20230509">SRRK</ix:nonNumeric><br />
              </div>
            </td>

    <td style="width: 38%; vertical-align: top; border-width: 2px; border-style: solid; border-color: rgb(0, 0, 0);">
              <div style="text-align: center;"><ix:nonNumeric name="dei:SecurityExchangeName" id="Fact_a2e8858a22694a81800d3f4109a2805e" contextRef="c20230509to20230509" format="ixt-sec:exchnameen">The Nasdaq Global Select Market</ix:nonNumeric><br />
              </div>
            </td>

  </tr>


</table>
      <div><br />
      </div>

      <div>&#160;</div>

      <div>Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR &#167;230.405) or Rule&#160;12b-2&#160;of the Securities Exchange Act of 1934 (17 CFR&#160;&#167;240.12b-2).&#160;Emerging growth company
        <ix:nonNumeric name="dei:EntityEmergingGrowthCompany" id="Fact_89738291756d4efc945653662e36aa22" contextRef="c20230509to20230509" format="ixt-sec:boolballotbox">&#x2612;</ix:nonNumeric></div>

      <div>&#160;</div>

      <div>If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange
        Act.&#160; <ix:nonNumeric name="dei:EntityExTransitionPeriod" id="Fact_0a18dbc783c1410d8d21d2a2a6c3f052" contextRef="c20230509to20230509" format="ixt-sec:boolballotbox">&#x2612;</ix:nonNumeric></div>

      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" /></div>

      </div>

      <div>
        <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;"> <br />
        </div>

        <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">Item 2.02. Results of Operations and Financial Condition.</div>

        <div><br />
        </div>

        <div>
          <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">On May 9, 2023, Scholar Rock Holding Corporation (the &#8220;Company&#8221;) issued a press release announcing its financial and operating
            results for the quarter ended March 31, 2023. A copy of the press release is being furnished as Exhibit 99.1 to this Report on Form 8-K.</div>

          <div><br />
          </div>

          <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">The information in this Report on Form 8-K and Exhibit 99.1 attached hereto is intended to be furnished and shall not be deemed
            &#8220;filed&#8221; for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the
            Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such filing.</div>

        </div>

        <div><br />
        </div>

        <div><br />
        </div>

        <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">Item 9.01. Financial Statements and Exhibits.</div>

        <div>&#160;</div>

        <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">(d) Exhibits</div>

        <div>&#160;</div>

        <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">


  <tr>

    <td style="width: 5%; vertical-align: middle; border-bottom: 2px solid rgb(0, 0, 0);">
                <div style="text-align: center; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">Exhibit</div>
                <div style="text-align: center; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">No.</div>
              </td>

    <td style="width: 0.66%; vertical-align: middle;">
                <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
              </td>

    <td style="width: 94%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">Description</div>
              </td>

  </tr>

  <tr>

    <td style="width: 5%; vertical-align: middle;">
                <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
              </td>

    <td style="width: 0.66%; vertical-align: middle;">
                <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
              </td>

    <td style="width: 94%; vertical-align: middle;">
                <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
              </td>

  </tr>

  <tr>

    <td style="width: 5%; vertical-align: middle;">
                <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><a href="#a53395784ex99_1.htm">99.1</a></div>
              </td>

    <td style="width: 0.66%; vertical-align: middle;">
                <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
              </td>

    <td style="width: 94%; vertical-align: middle;">
                <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><a href="#a53395784ex99_1.htm">Press Release issued by the Company
                    on May 9, 2023, furnished hereto</a>.</div>
              </td>

  </tr>

  <tr>

    <td style="width: 5%; vertical-align: middle;">
                <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">104</div>
              </td>

    <td style="width: 0.66%; vertical-align: middle;">&#160;</td>

    <td style="width: 94%; vertical-align: middle;">
                <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Cover Page Interactive Data File (embedded within the Inline XBRL document)</div>
              </td>

  </tr>


</table>
        <div> <br />
        </div>

        <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
          <div class="BRPFPageBreak" style="page-break-after: always;">
            <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" /></div>

        </div>

        <div> <br />
        </div>

        <div style="text-align: center; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">SIGNATURE</div>

        <div>&#160;</div>

        <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the
          undersigned hereunto duly authorized.</div>

        <div>&#160;</div>

        <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">


  <tr>

    <td style="width: 50%; vertical-align: top;">&#160;</td>

    <td colspan="2" style="vertical-align: top;">
                <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">Scholar Rock Holding Corporation</div>
              </td>

  </tr>

  <tr>

    <td style="width: 50%; vertical-align: top;">&#160;</td>

    <td style="width: 3%; vertical-align: top;">&#160;</td>

    <td style="width: 47%; vertical-align: top;">&#160;</td>

  </tr>

  <tr>

    <td style="width: 50%; vertical-align: top;">&#160;</td>

    <td style="width: 3%; vertical-align: top;">&#160;</td>

    <td style="width: 47%; vertical-align: top;">&#160;</td>

  </tr>

  <tr>

    <td style="width: 50%; vertical-align: top;">
                <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Date: May 9, 2023</div>
              </td>

    <td style="width: 3%; vertical-align: top;">
                <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">By:</div>
              </td>

    <td style="width: 47%; vertical-align: top;">
                <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><span style="text-decoration: underline;">/s/ Junlin Ho</span></div>
              </td>

  </tr>

  <tr>

    <td style="width: 50%; vertical-align: top;">&#160;</td>

    <td style="width: 3%; vertical-align: top;">&#160;</td>

    <td style="width: 47%; vertical-align: top;">
                <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Junlin Ho</div>
              </td>

  </tr>

  <tr>

    <td style="width: 50%; vertical-align: top;">&#160;</td>

    <td style="width: 3%; vertical-align: top;">&#160;</td>

    <td style="width: 47%; vertical-align: top;">
                <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">General Counsel and Corporate Secretary</div>
              </td>

  </tr>


</table>
        <div><br />
        </div>

        <div><br />
        </div>

      </div>

    </div>

  </div>

</body>

<!-- Mirrored from investors.scholarrock.com/node/9441/html by HTTrack Website Copier/3.x [XR&CO'2014], Sat, 21 Dec 2024 12:08:07 GMT -->
</html>
</XBRL>
<div><a name="a53395784ex99_1.htm"></a></div><html>
  <head>
    <title></title>
    <!-- Licensed to: businesswire
         Document created using Broadridge PROfile 23.3.1.5138
         Copyright 1995 - 2023 Broadridge -->
  
                    <script>var w=window;if(w.performance||w.mozPerformance||w.msPerformance||w.webkitPerformance){var d=document;AKSB=w.AKSB||{},AKSB.q=AKSB.q||[],AKSB.mark=AKSB.mark||function(e,_){AKSB.q.push(["mark",e,_||(new Date).getTime()])},AKSB.measure=AKSB.measure||function(e,_,t){AKSB.q.push(["measure",e,_,t||(new Date).getTime()])},AKSB.done=AKSB.done||function(e){AKSB.q.push(["done",e])},AKSB.mark("firstbyte",(new Date).getTime()),AKSB.prof={custid:"543865",ustr:"",originlat:"0",clientrtt:"426",ghostip:"23.62.181.15",ipv6:false,pct:"10",clientip:"105.119.6.83",requestid:"3791f239",region:"42877",protocol:"",blver:14,akM:"dsca",akN:"ae",akTT:"O",akTX:"1",akTI:"3791f239",ai:"505979",ra:"false",pmgn:"",pmgi:"",pmp:"",qc:""},function(e){var _=d.createElement("script");_.async="async",_.src=e;var t=d.getElementsByTagName("script"),t=t[t.length-1];t.parentNode.insertBefore(_,t)}(("https:"===d.location.protocol?"https:":"http:")+"//ds-aksb-a.akamaihd.net/aksb.min.js")}</script>
                    </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left; color: #000000;">
  <div>
    <table cellspacing="0" cellpadding="0" border="0" id="zc37e3fc3f2a44c6dbb43b44300e44b86" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; color: #000000; width: 100%;">

        <tr>
          <td style="width: 100%; text-align: right;"><font style="font-weight: bold;">Exhibit 99.1</font><br>
          </td>
        </tr>

    </table>
    <div> <br>
    </div>
    <div>
      <div class="bw-release">
        <h1 style="text-align: center; list-style-position: inside;FONT-SIZE: 14pt;"> <b>Scholar Rock Reports First Quarter 2023 Financial Results and Highlights Business Progress</b> </h1>
        <div class="bw-release-subhead">
          <p style="text-align: center; list-style-position: inside;"><b> - <i>Enrollment of pivotal Phase 3 SAPPHIRE trial evaluating apitegromab on track for completion in 2023</i> </b></p>
          <p style="text-align: center; list-style-position: inside;"><b> - <i>Upcoming presentations of 36-month apitegromab data from Phase 2 TOPAZ trial at Cure SMA&#8217;s Annual Research &amp; Clinical Conference</i> </b></p>
          <p style="text-align: center; list-style-position: inside;"><b> - <i>Continued advancement of Phase 1 DRAGON trial of SRK-181; biomarker and clinical data update planned in the second half of 2023</i> </b></p>
          <p style="text-align: center; list-style-position: inside;"><b> <i>- Approximately $275 million in cash, cash equivalents, and marketable securities as of March 31, 2023, expected to fund operations into 2025</i> </b></p>
        </div>
        <div class="bw-release-body">
          <div class="bw-release-table-js bw-release-story">
            <p>CAMBRIDGE, Mass.--(BUSINESS WIRE)--May 9, 2023--Scholar Rock (NASDAQ: SRRK), a Phase 3 clinical-stage biopharmaceutical company focused on the treatment of serious diseases in which protein growth factors play a fundamental role, today
              reported financial results and corporate updates for the first quarter ended March 31, 2023. </p>
            <p> &#8220;We are executing across our business and leveraging Scholar Rock&#8217;s differentiated platform, which selectively targets latent forms of growth factors, such as myostatin and TGF&#946;1, to develop highly selective and potentially transformative
              therapies for patients who have high unmet medical need,&#8221; said Jay Backstrom, M.D., M.P.H., President &amp; Chief Executive Officer of Scholar Rock. &#8220;We continue to advance our two clinical programs in spinal muscular atrophy and oncology,
              and we look forward to sharing updates on our progress as we approach several key milestones, including presenting 36-month data on apitegromab from the Phase 2 TOPAZ trial, completing enrollment of our apitegromab Phase 3 SAPPHIRE trial, and
              providing biomarker and clinical updates from our SRK-181 Phase 1 DRAGON trial.&#8221; </p>
            <p> <b>Recent Company Highlights and Upcoming Milestones</b> </p>
            <p> <b><u>Apitegromab</u></b> is an investigational antibody inhibiting myostatin activation by selectively binding the pro- and latent forms of myostatin and is being developed as the potential first muscle-targeted
              therapy for the treatment of spinal muscular atrophy (SMA). </p>
            <ul style="list-style-type: disc;">
              <li> <b>Continued progress towards completion of enrollment for Phase 3 SAPPHIRE clinical trial.</b> The randomized double-blind, placebo-controlled clinical trial evaluating apitegromab for patients with nonambulatory Types 2 and 3 SMA on
                either nusinersen or risdiplam, is actively enrolling SMA patients across sites in the U.S. and Europe. Enrollment completion is expected in 2023, with the top-line data readout expected in 2024. If successful and if approved, the company
                expects to initiate a commercial product launch in 2025. </li>
              <li> <b>36-month data from Phase 2 TOPAZ trial to be presented at Cure SMA conference in June</b>. The company announced two upcoming oral presentations at the Cure SMA Research &amp; Clinical Conference, taking place June 28-30 in Orlando,
                Florida. </li>
              <li> <b>24-month data from the TOPAZ trial presented at the 2023 Muscular Dystrophy Association (MDA) Clinical and Scientific Conference in March.</b> The company shared data evaluating outcomes after 24 months of treatment with apitegromab,
                demonstrating sustained improvements in motor function in patients with nonambulatory Types 2 and 3 SMA. </li>
            </ul>

            <div style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt" id="DSPFPageBreakArea">
              <div style="PAGE-BREAK-AFTER: always" id="DSPFPageBreak">
                <hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #000000"> </div>
            </div>
            <p> <b><u>SRK-181</u> </b>is an investigational selective inhibitor of latent TGF&#946;1 activation and is being developed with the aim of overcoming resistance to checkpoint therapy in patients with advanced cancer. </p>
            <ul style="list-style-type: disc;">
              <li> <b>Advancing Phase 1 DRAGON proof-of-concept trial.</b> In the second half of 2023, the company expects to provide biomarker and clinical updates from Part B of the DRAGON trial. In March 2023, Scholar Rock presented encore data at the
                European Society for Medical Oncology Targeted Anticancer Therapies (ESMO TAT) Congress, which showed that SRK-181 continued to be generally well tolerated with early indications of efficacy (as of the data cut-off date of December 2,
                2022). </li>
            </ul>
            <p> <b><u>Corporate</u></b> </p>
            <p style="margin-left: 30px;"> <b>Announced the addition of Richard Brudnick to the Board of Directors. </b>In April 2023, Mr.<b> </b>Brudnick joined Scholar Rock&#8217;s Board of Directors. As an accomplished biotechnology executive, he brings an
              extensive background in corporate development and strategy, with over 30 years of industry experience across multiple specialties, stages and therapeutic areas. </p>
            <p> <b>First Quarter 2023 Financial Results</b> </p>
            <p> For the quarter ended March 31, 2023, net loss was $39.4 million or $0.49 per share compared to a net loss of $8.0 million or $0.21 per share for the quarter ended March 31, 2022. </p>
            <ul style="list-style-type: disc;">
              <li> Revenue was $0 for the quarter ended March 31, 2023, compared to $33.2 million for the quarter ended March 31, 2022. The prior year revenue was related to the Gilead fibrosis-focused research collaboration, which was executed in December
                2018 and concluded in December 2021. </li>
            </ul>
            <ul style="list-style-type: disc;">
              <li> Research and development expense was $29.7 million for the quarter ended March 31, 2023, compared to $29.4 million for the quarter ended March 31, 2022. The increase was primarily attributable to costs associated with clinical trials,
                including the Phase 3 SAPPHIRE pivotal trial for apitegromab in SMA, and the DRAGON trial for SRK-181. These increases were offset by decreases in employee compensation and benefits costs, resulting from the restructuring in May 2022. </li>
            </ul>
            <ul style="list-style-type: disc;">
              <li> General and administrative expense was $10.8 million for the quarter ended March 31, 2023, compared to $10.8 million for the quarter ended March 31, 2022. </li>
            </ul>
            <ul style="list-style-type: disc;">
              <li> As of March 31, 2023, Scholar Rock had cash, cash equivalents, and marketable securities of approximately $275 million, which is expected to fund the company&#8217;s anticipated operating and capital expenditure requirements into 2025. </li>
            </ul>

            <div style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt" id="DSPFPageBreakArea">
              <div style="PAGE-BREAK-AFTER: always" id="DSPFPageBreak">
                <hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #000000"> </div>
            </div>
            <p> &#8220;Scholar Rock is in a strong financial position, and we are relentlessly focused on achieving our goal of improving the lives of patients who may potentially benefit from our medicines,&#8221; said Ted Myles, Chief Operating Officer and Chief
              Financial Officer of Scholar Rock. &#8220;We continue to execute on our plan by advancing our clinical programs towards key inflection points, while diligently managing our resources.&#8221; </p>
            <p> <b>About Scholar Rock</b> </p>
            <p> Scholar Rock is a clinical-stage biopharmaceutical company focused on the discovery and development of innovative medicines for the treatment of serious diseases in which signaling by protein growth factors plays a fundamental role. Scholar
              Rock is creating a pipeline of novel product candidates with the potential to transform the lives of patients suffering from a wide range of serious diseases, including neuromuscular disorders, cancer, fibrosis and anemia. Scholar Rock&#8217;s
              approach to targeting the molecular mechanisms of growth factor activation enabled it to develop a proprietary platform for the discovery and development of monoclonal antibodies that locally and selectively target these signaling proteins at
              the cellular level. By developing product candidates that act in the disease microenvironment, the company intends to avoid the historical challenges associated with inhibiting growth factors for therapeutic effect. Scholar Rock believes its
              focus on biologically validated growth factors may facilitate a more efficient development path. For more information, please visit www.scholarrock.com or follow Scholar Rock on Twitter (@ScholarRock) and LinkedIn
              (https://www.linkedin.com/company/scholar-rock/). </p>
            <p> <b>Availability of Other Information About Scholar Rock</b> </p>
            <p> Investors and others should note that we communicate with our investors and the public using our company website www.scholarrock.com, including, but not limited to, company disclosures, investor presentations and FAQs, Securities and
              Exchange Commission filings, press releases, public conference call transcripts and webcast transcripts, as well as on Twitter and LinkedIn. The information that we post on our website or on Twitter or LinkedIn could be deemed to be material
              information. As a result, we encourage investors, the media and others interested to review the information that we post there on a regular basis. The contents of our website or social media shall not be deemed incorporated by reference in
              any filing under the Securities Act of 1933, as amended. </p>
            <p> Scholar Rock&#174; is a registered trademark of Scholar Rock, Inc. </p>

            <div style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt" id="DSPFPageBreakArea">
              <div style="PAGE-BREAK-AFTER: always" id="DSPFPageBreak">
                <hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #000000"> </div>
            </div>
            <p> <b>Forward-Looking Statements</b> </p>
            <p> This press release contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements regarding Scholar Rock&#8217;s future expectations, plans and
              prospects, including without limitation, Scholar Rock&#8217;s expectations regarding its growth, strategy, progress and timing of its clinical trials for apitegromab, SRK-181, and other product candidates and indication selection and development
              timing, its cash runway, the ability of any product candidate to perform in humans in a manner consistent with earlier nonclinical, preclinical or clinical trial data, and the potential of its product candidates and proprietary platform.<i> </i>The
              use of words such as &#8220;may,&#8221; &#8220;might,&#8221; &#8220;could,&#8221; &#8220;will,&#8221; &#8220;should,&#8221; &#8220;expect,&#8221; &#8220;plan,&#8221; &#8220;anticipate,&#8221; &#8220;believe,&#8221; &#8220;estimate,&#8221; &#8220;project,&#8221; &#8220;intend,&#8221; &#8220;future,&#8221; &#8220;potential,&#8221; or &#8220;continue,&#8221; and other similar expressions are intended to identify such
              forward-looking statements. All such forward-looking statements are based on management's current expectations of future events and are subject to a number of risks and uncertainties that could cause actual results to differ materially and
              adversely from those set forth in or implied by such forward-looking statements. These risks and uncertainties include, without limitation, that preclinical and clinical data, including the results from the Phase 2 clinical trial of
              apitegromab, or Part A of the Phase 1 clinical trial of SRK-181, are not predictive of, may be inconsistent with, or more favorable than, data generated from future clinical trials of the same product candidates, including, without
              limitation, the Phase 3 clinical trial of apitegromab in SMA or Part B of the Phase 1 clinical trial of SRK-181; Scholar Rock&#8217;s ability to provide the financial support, resources and expertise necessary to identify and develop product
              candidates on the expected timeline; the data generated from Scholar Rock&#8217;s nonclinical and preclinical studies and clinical trials; information provided or decisions made by regulatory authorities; competition from third parties that are
              developing products for similar uses; Scholar Rock&#8217;s ability to obtain, maintain and protect its intellectual property; Scholar Rock&#8217;s dependence on third parties for development and manufacture of product candidates including, without
              limitation, to supply any clinical trials; Scholar Rock&#8217;s ability to manage expenses and to obtain additional funding when needed to support its business activities and establish and maintain strategic business alliances and new business
              initiatives, and the impacts of public health pandemics such as COVID-19 on business operations and expectations, as well as those risks more fully discussed in the section entitled "Risk Factors" in Scholar Rock&#8217;s Quarterly Report on Form
              10-Q for the quarter ended March 31, 2023, as well as discussions of potential risks, uncertainties, and other important factors in Scholar Rock&#8217;s subsequent filings with the Securities and Exchange Commission. Any forward-looking statements
              represent Scholar Rock&#8217;s views only as of today and should not be relied upon as representing its views as of any subsequent date. All information in this press release is as of the date of the release, and Scholar Rock undertakes no duty to
              update this information unless required by law. </p>

            <div style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt" id="DSPFPageBreakArea">
              <div style="PAGE-BREAK-AFTER: always" id="DSPFPageBreak">
                <hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #000000"> </div>
            </div>
            <table cellspacing="0" id="z2fa4bd1749f549f595ebbd7757ca46fe" style="margin-bottom: 10px;margin-left: 0px; margin-right: auto; font-size: 10pt;">

                <tr>
                  <td rowspan="1" style="vertical-align: bottom;padding-left: 0px;text-align: center; list-style-position: inside;" colspan="7">
                    <p style="text-align: center; list-style-position: inside;margin-bottom: 0px; margin-top: 0px;"> <b>Scholar Rock Holding Corporation</b> </p>
                  </td>
                </tr>
                <tr>
                  <td rowspan="1" style="vertical-align: bottom;padding-left: 0px;text-align: center; list-style-position: inside;" colspan="7">
                    <p style="text-align: center; list-style-position: inside;margin-bottom: 0px; margin-top: 0px;"> <b>Condensed Consolidated Statements of Operations</b> </p>
                  </td>
                </tr>
                <tr>
                  <td rowspan="1" style="vertical-align: bottom;padding-left: 0px;text-align: center; list-style-position: inside;" colspan="7">
                    <p style="text-align: center; list-style-position: inside;margin-bottom: 0px; margin-top: 0px;"> (unaudited) </p>
                  </td>
                </tr>
                <tr>
                  <td rowspan="1" style="vertical-align: bottom;padding-left: 0px;text-align: center; list-style-position: inside;" colspan="7">
                    <p style="text-align: center; list-style-position: inside;margin-bottom: 0px; margin-top: 0px;"> (in thousands, except share and per share data) </p>
                  </td>
                </tr>
                <tr>
                  <td colspan="1" rowspan="1" style="vertical-align: bottom;padding-left: 0px;"><br>
                  </td>
                  <td colspan="1" rowspan="1"><br>
                  </td>
                  <td rowspan="1" style="vertical-align: bottom;padding-left: 0px;" colspan="2"><br>
                  </td>
                  <td colspan="1" rowspan="1" style="vertical-align: bottom;padding-left: 0px;"><br>
                  </td>
                  <td rowspan="1" style="vertical-align: bottom;padding-left: 0px;" colspan="2">&#160;</td>
                </tr>
                <tr>
                  <td colspan="1" rowspan="1" style="vertical-align: bottom;padding-left: 0px;"><br>
                  </td>
                  <td colspan="1" rowspan="1"><br>
                  </td>
                  <td rowspan="1" style="vertical-align: bottom;padding-left: 0px;" colspan="2"><br>
                  </td>
                  <td colspan="1" rowspan="1" style="vertical-align: bottom;padding-left: 0px;"><br>
                  </td>
                  <td rowspan="1" style="vertical-align: bottom;padding-left: 0px;" colspan="2">&#160;</td>
                </tr>
                <tr>
                  <td colspan="1" rowspan="1" style="vertical-align: bottom;padding-left: 0px;"><br>
                  </td>
                  <td colspan="1" rowspan="1"><br>
                  </td>
                  <td rowspan="1" style="vertical-align: bottom;padding-left: 0px;white-space: nowrap;text-align: center; list-style-position: inside;" colspan="5">
                    <p style="margin-bottom: 0px; margin-top: 0px;text-align: center; list-style-position: inside;"> <b>Three Months Ended March 31</b> </p>
                  </td>
                </tr>
                <tr>
                  <td colspan="1" rowspan="1" style="vertical-align: bottom;padding-left: 0px;"><br>
                  </td>
                  <td colspan="1" rowspan="1"><br>
                  </td>
                  <td rowspan="1" style="vertical-align: bottom;border-bottom: solid black 1pt;padding-left: 0px;padding-right: 0px;text-align: center; list-style-position: inside;" colspan="2">
                    <p style="margin-bottom: 0px; margin-top: 0px;text-align: center; list-style-position: inside;"> <b>2023</b> </p>
                  </td>
                  <td colspan="1" rowspan="1" style="vertical-align: bottom;padding-left: 0px;"><br>
                  </td>
                  <td rowspan="1" style="vertical-align: bottom;border-bottom: solid black 1pt;padding-left: 0px;padding-right: 0px;text-align: center; list-style-position: inside;" colspan="2">
                    <p style="margin-bottom: 0px; margin-top: 0px;text-align: center; list-style-position: inside;"> <b>2022</b> </p>
                  </td>
                </tr>
                <tr>
                  <td colspan="1" rowspan="1" style="vertical-align: bottom;padding-left: 0px;"><br>
                  </td>
                  <td colspan="1" rowspan="1"><br>
                  </td>
                  <td rowspan="1" style="vertical-align: bottom;padding-left: 0px;" colspan="2"><br>
                  </td>
                  <td colspan="1" rowspan="1" style="vertical-align: bottom;padding-left: 0px;"><br>
                  </td>
                  <td rowspan="1" style="vertical-align: bottom;padding-left: 0px;" colspan="2">&#160;</td>
                </tr>
                <tr>
                  <td colspan="1" rowspan="1" style="vertical-align: bottom;padding-left: 0px;">
                    <p style="margin-bottom: 0px; margin-top: 0px;"> Revenue </p>
                  </td>
                  <td colspan="1" rowspan="1"><br>
                  </td>
                  <td colspan="1" rowspan="1" style="vertical-align: bottom;padding-left: 0px;padding-right: 0px;">
                    <p style="text-align: right; list-style-position: inside;margin-bottom: 0px; margin-top: 0px;"> $ </p>
                  </td>
                  <td colspan="1" rowspan="1" style="vertical-align: bottom;padding-left: 0px;padding-right: 0px;">
                    <p style="text-align: right; list-style-position: inside;margin-bottom: 0px; margin-top: 0px;"> &#8212; </p>
                  </td>
                  <td colspan="1" rowspan="1" style="vertical-align: bottom;padding-left: 0px;"><br>
                  </td>
                  <td colspan="1" rowspan="1" style="vertical-align: bottom;padding-left: 0px;padding-right: 0px;">
                    <p style="text-align: right; list-style-position: inside;margin-bottom: 0px; margin-top: 0px;"> $ </p>
                  </td>
                  <td colspan="1" rowspan="1" style="vertical-align: bottom;padding-left: 0px;padding-right: 0px;">
                    <p style="text-align: right; list-style-position: inside;margin-bottom: 0px; margin-top: 0px;"> 33,193 </p>
                  </td>
                </tr>
                <tr>
                  <td colspan="1" rowspan="1" style="vertical-align: bottom;padding-left: 0px;"><br>
                  </td>
                  <td colspan="1" rowspan="1"><br>
                  </td>
                  <td rowspan="1" style="vertical-align: bottom;padding-left: 0px;" colspan="2"><br>
                  </td>
                  <td colspan="1" rowspan="1" style="vertical-align: bottom;padding-left: 0px;"><br>
                  </td>
                  <td rowspan="1" style="vertical-align: bottom;padding-left: 0px;" colspan="2">&#160;</td>
                </tr>
                <tr>
                  <td colspan="1" rowspan="1" style="vertical-align: bottom;padding-left: 0px;">
                    <p style="margin-bottom: 0px; margin-top: 0px;"> Operating expenses </p>
                  </td>
                  <td colspan="1" rowspan="1"><br>
                  </td>
                  <td rowspan="1" style="vertical-align: bottom;padding-left: 0px;" colspan="2"><br>
                  </td>
                  <td colspan="1" rowspan="1" style="vertical-align: bottom;padding-left: 0px;"><br>
                  </td>
                  <td rowspan="1" style="vertical-align: bottom;padding-left: 0px;" colspan="2"><br>
                  </td>
                </tr>
                <tr>
                  <td colspan="1" rowspan="1" style="vertical-align: bottom;padding-left: 15px;">Research and development</td>
                  <td colspan="1" rowspan="1"><br>
                  </td>
                  <td colspan="1" rowspan="1" style="vertical-align: bottom;padding-left: 0px;padding-right: 0px;">
                    <p style="text-align: right; list-style-position: inside;margin-bottom: 0px; margin-top: 0px;"> &#160; </p>
                  </td>
                  <td colspan="1" rowspan="1" style="vertical-align: bottom;padding-left: 0px;padding-right: 0px;">
                    <p style="text-align: right; list-style-position: inside;margin-bottom: 0px; margin-top: 0px;"> 29,735 </p>
                  </td>
                  <td colspan="1" rowspan="1" style="vertical-align: bottom;padding-left: 0px;"><br>
                  </td>
                  <td colspan="1" rowspan="1" style="vertical-align: bottom;padding-left: 0px;padding-right: 0px;">
                    <p style="text-align: right; list-style-position: inside;margin-bottom: 0px; margin-top: 0px;"> &#160; </p>
                  </td>
                  <td colspan="1" rowspan="1" style="vertical-align: bottom;padding-left: 0px;padding-right: 0px;">
                    <p style="text-align: right; list-style-position: inside;margin-bottom: 0px; margin-top: 0px;"> 29,366 </p>
                  </td>
                </tr>
                <tr>
                  <td colspan="1" rowspan="1" style="vertical-align: bottom;padding-left: 15px;">General and administrative</td>
                  <td colspan="1" rowspan="1"><br>
                  </td>
                  <td colspan="1" rowspan="1" style="vertical-align: bottom;padding-left: 0px;border-bottom: solid black 1pt;padding-right: 0px;">
                    <p style="text-align: right; list-style-position: inside;margin-bottom: 0px; margin-top: 0px;"> &#160; </p>
                  </td>
                  <td colspan="1" rowspan="1" style="vertical-align: bottom;padding-left: 0px;border-bottom: solid black 1pt;padding-right: 0px;">
                    <p style="text-align: right; list-style-position: inside;margin-bottom: 0px; margin-top: 0px;"> 10,774 </p>
                  </td>
                  <td colspan="1" rowspan="1" style="vertical-align: bottom;padding-left: 0px;"><br>
                  </td>
                  <td colspan="1" rowspan="1" style="vertical-align: bottom;padding-left: 0px;border-bottom: solid black 1pt;padding-right: 0px;">
                    <p style="text-align: right; list-style-position: inside;margin-bottom: 0px; margin-top: 0px;"> &#160; </p>
                  </td>
                  <td colspan="1" rowspan="1" style="vertical-align: bottom;padding-left: 0px;border-bottom: solid black 1pt;padding-right: 0px;">
                    <p style="text-align: right; list-style-position: inside;margin-bottom: 0px; margin-top: 0px;"> 10,760 </p>
                  </td>
                </tr>
                <tr>
                  <td colspan="1" rowspan="1" style="vertical-align: bottom;padding-left: 0px;">
                    <p style="margin-bottom: 0px; margin-top: 0px;"> Total operating expenses </p>
                  </td>
                  <td colspan="1" rowspan="1"><br>
                  </td>
                  <td colspan="1" rowspan="1" style="vertical-align: bottom;padding-left: 0px;border-bottom: solid black 1pt;padding-right: 0px;">
                    <p style="text-align: right; list-style-position: inside;margin-bottom: 0px; margin-top: 0px;"> &#160; </p>
                  </td>
                  <td colspan="1" rowspan="1" style="vertical-align: bottom;padding-left: 0px;border-bottom: solid black 1pt;padding-right: 0px;">
                    <p style="text-align: right; list-style-position: inside;margin-bottom: 0px; margin-top: 0px;"> 40,509 </p>
                  </td>
                  <td colspan="1" rowspan="1" style="vertical-align: bottom;padding-left: 0px;"><br>
                  </td>
                  <td colspan="1" rowspan="1" style="vertical-align: bottom;padding-left: 0px;border-bottom: solid black 1pt;padding-right: 0px;">
                    <p style="text-align: right; list-style-position: inside;margin-bottom: 0px; margin-top: 0px;"> &#160; </p>
                  </td>
                  <td colspan="1" rowspan="1" style="vertical-align: bottom;padding-left: 0px;border-bottom: solid black 1pt;padding-right: 0px;">
                    <p style="text-align: right; list-style-position: inside;margin-bottom: 0px; margin-top: 0px;"> 40,126 </p>
                  </td>
                </tr>
                <tr>
                  <td colspan="1" rowspan="1" style="vertical-align: bottom;padding-left: 0px;">
                    <p style="margin-bottom: 0px; margin-top: 0px;"> Loss from operations </p>
                  </td>
                  <td colspan="1" rowspan="1"><br>
                  </td>
                  <td colspan="1" rowspan="1" style="vertical-align: bottom;padding-left: 0px;padding-right: 0px;">
                    <p style="text-align: right; list-style-position: inside;margin-bottom: 0px; margin-top: 0px;"> &#160; </p>
                  </td>
                  <td colspan="1" rowspan="1" style="vertical-align: bottom;padding-left: 0px;padding-right: 0px;">
                    <p style="text-align: right; list-style-position: inside;margin-bottom: 0px; margin-top: 0px;"> (40,509) </p>
                  </td>
                  <td colspan="1" rowspan="1" style="vertical-align: bottom;padding-left: 0px;"><br>
                  </td>
                  <td colspan="1" rowspan="1" style="vertical-align: bottom;padding-left: 0px;padding-right: 0px;">
                    <p style="text-align: right; list-style-position: inside;margin-bottom: 0px; margin-top: 0px;"> &#160; </p>
                  </td>
                  <td colspan="1" rowspan="1" style="vertical-align: bottom;padding-left: 0px;padding-right: 0px;">
                    <p style="text-align: right; list-style-position: inside;margin-bottom: 0px; margin-top: 0px;"> (6,933) </p>
                  </td>
                </tr>
                <tr>
                  <td colspan="1" rowspan="1" style="vertical-align: bottom;padding-left: 0px;">
                    <p style="margin-bottom: 0px; margin-top: 0px;"> Other income (expense), net </p>
                  </td>
                  <td colspan="1" rowspan="1"><br>
                  </td>
                  <td colspan="1" rowspan="1" style="vertical-align: bottom;padding-left: 0px;border-bottom: solid black 1pt;padding-right: 0px;">
                    <p style="text-align: right; list-style-position: inside;margin-bottom: 0px; margin-top: 0px;"> &#160; </p>
                  </td>
                  <td colspan="1" rowspan="1" style="vertical-align: bottom;padding-left: 0px;border-bottom: solid black 1pt;padding-right: 0px;">
                    <p style="text-align: right; list-style-position: inside;margin-bottom: 0px; margin-top: 0px;"> 1,130 </p>
                  </td>
                  <td colspan="1" rowspan="1" style="vertical-align: bottom;padding-left: 0px;"><br>
                  </td>
                  <td colspan="1" rowspan="1" style="vertical-align: bottom;padding-left: 0px;border-bottom: solid black 1pt;padding-right: 0px;">
                    <p style="text-align: right; list-style-position: inside;margin-bottom: 0px; margin-top: 0px;"> &#160; </p>
                  </td>
                  <td colspan="1" rowspan="1" style="vertical-align: bottom;padding-left: 0px;border-bottom: solid black 1pt;padding-right: 0px;">
                    <p style="text-align: right; list-style-position: inside;margin-bottom: 0px; margin-top: 0px;"> (1,017) </p>
                  </td>
                </tr>
                <tr>
                  <td colspan="1" rowspan="1" style="vertical-align: bottom;padding-left: 0px;">
                    <p style="margin-bottom: 0px; margin-top: 0px;"> Net loss </p>
                  </td>
                  <td colspan="1" rowspan="1"><br>
                  </td>
                  <td colspan="1" rowspan="1" style="vertical-align: bottom;border-bottom: double black 2.25pt;padding-left: 0px;padding-right: 0px;">
                    <p style="text-align: right; list-style-position: inside;margin-bottom: 0px; margin-top: 0px;"> $ </p>
                  </td>
                  <td colspan="1" rowspan="1" style="vertical-align: bottom;border-bottom: double black 2.25pt;padding-left: 0px;padding-right: 0px;">
                    <p style="text-align: right; list-style-position: inside;margin-bottom: 0px; margin-top: 0px;"> (39,379) </p>
                  </td>
                  <td colspan="1" rowspan="1" style="vertical-align: bottom;padding-left: 0px;"><br>
                  </td>
                  <td colspan="1" rowspan="1" style="vertical-align: bottom;border-bottom: double black 2.25pt;padding-left: 0px;padding-right: 0px;">
                    <p style="text-align: right; list-style-position: inside;margin-bottom: 0px; margin-top: 0px;"> $ </p>
                  </td>
                  <td colspan="1" rowspan="1" style="vertical-align: bottom;border-bottom: double black 2.25pt;padding-left: 0px;padding-right: 0px;">
                    <p style="text-align: right; list-style-position: inside;margin-bottom: 0px; margin-top: 0px;"> (7,950) </p>
                  </td>
                </tr>
                <tr>
                  <td colspan="1" rowspan="1" style="vertical-align: bottom;padding-left: 0px;"><br>
                  </td>
                  <td colspan="1" rowspan="1"><br>
                  </td>
                  <td rowspan="1" style="vertical-align: bottom;padding-left: 0px;" colspan="2"><br>
                  </td>
                  <td colspan="1" rowspan="1" style="vertical-align: bottom;padding-left: 0px;"><br>
                  </td>
                  <td rowspan="1" style="vertical-align: bottom;padding-left: 0px;" colspan="2">&#160;</td>
                </tr>
                <tr>
                  <td colspan="1" rowspan="1" style="vertical-align: bottom;padding-left: 0px;">
                    <p style="margin-bottom: 0px; margin-top: 0px;"> Net loss per share, basic and diluted </p>
                  </td>
                  <td colspan="1" rowspan="1"><br>
                  </td>
                  <td colspan="1" rowspan="1" style="vertical-align: bottom;border-bottom: double black 2.25pt;padding-left: 0px;padding-right: 0px;">
                    <p style="text-align: right; list-style-position: inside;margin-bottom: 0px; margin-top: 0px;"> $ </p>
                  </td>
                  <td colspan="1" rowspan="1" style="vertical-align: bottom;border-bottom: double black 2.25pt;padding-left: 0px;padding-right: 0px;">
                    <p style="text-align: right; list-style-position: inside;margin-bottom: 0px; margin-top: 0px;"> (0.49) </p>
                  </td>
                  <td colspan="1" rowspan="1" style="vertical-align: bottom;padding-left: 0px;"><br>
                  </td>
                  <td colspan="1" rowspan="1" style="vertical-align: bottom;border-bottom: double black 2.25pt;padding-left: 0px;padding-right: 0px;">
                    <p style="text-align: right; list-style-position: inside;margin-bottom: 0px; margin-top: 0px;"> $ </p>
                  </td>
                  <td colspan="1" rowspan="1" style="vertical-align: bottom;border-bottom: double black 2.25pt;padding-left: 0px;padding-right: 0px;">
                    <p style="text-align: right; list-style-position: inside;margin-bottom: 0px; margin-top: 0px;"> (0.21) </p>
                  </td>
                </tr>
                <tr>
                  <td colspan="1" rowspan="1" style="vertical-align: bottom;padding-left: 0px;"><br>
                  </td>
                  <td colspan="1" rowspan="1"><br>
                  </td>
                  <td rowspan="1" style="vertical-align: bottom;padding-left: 0px;" colspan="2"><br>
                  </td>
                  <td colspan="1" rowspan="1" style="vertical-align: bottom;padding-left: 0px;"><br>
                  </td>
                  <td rowspan="1" style="vertical-align: bottom;padding-left: 0px;" colspan="2">&#160;</td>
                </tr>
                <tr>
                  <td colspan="1" rowspan="1" style="vertical-align: bottom;padding-left: 0px;">
                    <p style="margin-bottom: 0px; margin-top: 0px;"> Weighted average common shares outstanding, basic and diluted </p>
                  </td>
                  <td colspan="1" rowspan="1"><br>
                  </td>
                  <td colspan="1" rowspan="1" style="vertical-align: bottom;border-bottom: double black 2.25pt;padding-left: 0px;padding-right: 0px;">
                    <p style="text-align: right; list-style-position: inside;margin-bottom: 0px; margin-top: 0px;"> &#160; </p>
                  </td>
                  <td colspan="1" rowspan="1" style="vertical-align: bottom;border-bottom: double black 2.25pt;padding-left: 0px;padding-right: 0px;">
                    <p style="text-align: right; list-style-position: inside;margin-bottom: 0px; margin-top: 0px;"> 79,610,059 </p>
                  </td>
                  <td colspan="1" rowspan="1" style="vertical-align: bottom;padding-left: 0px;"><br>
                  </td>
                  <td colspan="1" rowspan="1" style="vertical-align: bottom;border-bottom: double black 2.25pt;padding-left: 0px;padding-right: 0px;">
                    <p style="text-align: right; list-style-position: inside;margin-bottom: 0px; margin-top: 0px;"> &#160; </p>
                  </td>
                  <td colspan="1" rowspan="1" style="vertical-align: bottom;border-bottom: double black 2.25pt;padding-left: 0px;padding-right: 0px;">
                    <p style="text-align: right; list-style-position: inside;margin-bottom: 0px; margin-top: 0px;"> 37,456,574 </p>
                  </td>
                </tr>
                <tr>
                  <td colspan="1" rowspan="1" style="vertical-align: bottom;padding-left: 0px;"><br>
                  </td>
                  <td colspan="1" rowspan="1"><br>
                  </td>
                  <td rowspan="1" style="vertical-align: bottom;padding-left: 0px;" colspan="2"><br>
                  </td>
                  <td colspan="1" rowspan="1" style="vertical-align: bottom;padding-left: 0px;"><br>
                  </td>
                  <td rowspan="1" style="vertical-align: bottom;padding-left: 0px;" colspan="2">&#160;</td>
                </tr>

            </table>

            <div style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt" id="DSPFPageBreakArea">
              <div style="PAGE-BREAK-AFTER: always" id="DSPFPageBreak">
                <hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #000000"> </div>
            </div>
            <table cellspacing="0" id="za1d86ec293014100bd9d5808a21404c1" style="margin-bottom: 10px;margin-left: 0px; margin-right: auto; font-size: 10pt;">

                <tr>
                  <td rowspan="1" style="vertical-align: bottom;padding-left: 0px;text-align: center; list-style-position: inside;" colspan="7"><b>Scholar Rock Holding Corporation</b></td>
                </tr>
                <tr>
                  <td rowspan="1" style="vertical-align: bottom;padding-left: 0px;text-align: center; list-style-position: inside;" colspan="7">
                    <p style="text-align: center; list-style-position: inside;margin-bottom: 0px; margin-top: 0px;"> <b>Condensed Consolidated Balance Sheets</b> </p>
                  </td>
                </tr>
                <tr>
                  <td rowspan="1" style="vertical-align: bottom;padding-left: 0px;text-align: center; list-style-position: inside;" colspan="7">
                    <p style="text-align: center; list-style-position: inside;margin-bottom: 0px; margin-top: 0px;"> (unaudited) </p>
                  </td>
                </tr>
                <tr>
                  <td rowspan="1" style="vertical-align: bottom;padding-left: 0px;text-align: center; list-style-position: inside;" colspan="7">
                    <p style="text-align: center; list-style-position: inside;margin-bottom: 0px; margin-top: 0px;"> (in thousands) </p>
                  </td>
                </tr>
                <tr>
                  <td colspan="1" rowspan="1" style="vertical-align: bottom;padding-left: 0px;"><br>
                  </td>
                  <td colspan="1" rowspan="1"><br>
                  </td>
                  <td rowspan="1" style="vertical-align: bottom;padding-left: 0px;" colspan="2"><br>
                  </td>
                  <td colspan="1" rowspan="1" style="vertical-align: bottom;padding-left: 0px;"><br>
                  </td>
                  <td rowspan="1" style="vertical-align: bottom;padding-left: 0px;" colspan="2">&#160;</td>
                </tr>
                <tr>
                  <td colspan="1" rowspan="1" style="vertical-align: bottom;padding-left: 0px;"><br>
                  </td>
                  <td colspan="1" rowspan="1"><br>
                  </td>
                  <td rowspan="1" style="vertical-align: bottom;border-bottom: solid black 1pt;padding-left: 0px;text-align: center; list-style-position: inside;white-space: nowrap;" colspan="2">
                    <p style="text-align: center; list-style-position: inside;margin-bottom: 0px; margin-top: 0px;"> <b>March 31, 2023</b> </p>
                  </td>
                  <td colspan="1" rowspan="1" style="vertical-align: bottom;padding-left: 0px;"><br>
                  </td>
                  <td rowspan="1" style="vertical-align: bottom;border-bottom: solid black 1pt;padding-left: 0px;text-align: center; list-style-position: inside;white-space: nowrap;" colspan="2">
                    <p style="text-align: center; list-style-position: inside;margin-bottom: 0px; margin-top: 0px;"> <b>December 31, 2022</b> </p>
                  </td>
                </tr>
                <tr>
                  <td colspan="1" rowspan="1" style="vertical-align: bottom;padding-left: 0px;">
                    <p style="margin-bottom: 0px; margin-top: 0px;"> <b>Assets</b> </p>
                  </td>
                  <td colspan="1" rowspan="1"><br>
                  </td>
                  <td rowspan="1" style="vertical-align: bottom;padding-left: 0px;" colspan="2"><br>
                  </td>
                  <td colspan="1" rowspan="1" style="vertical-align: bottom;padding-left: 0px;"><br>
                  </td>
                  <td rowspan="1" style="vertical-align: bottom;padding-left: 0px;" colspan="2"><br>
                  </td>
                </tr>
                <tr>
                  <td colspan="1" rowspan="1" style="vertical-align: bottom;padding-left: 20px;">Cash, cash equivalents and marketable securities</td>
                  <td colspan="1" rowspan="1"><br>
                  </td>
                  <td colspan="1" rowspan="1" style="vertical-align: bottom;padding-left: 0px;padding-right: 0px;">
                    <p style="text-align: right; list-style-position: inside;margin-bottom: 0px; margin-top: 0px;"> $ </p>
                  </td>
                  <td colspan="1" rowspan="1" style="vertical-align: bottom;padding-left: 0px;padding-right: 0px;">
                    <p style="text-align: right; list-style-position: inside;margin-bottom: 0px; margin-top: 0px;"> 275,284 </p>
                  </td>
                  <td colspan="1" rowspan="1" style="vertical-align: bottom;padding-left: 0px;"><br>
                  </td>
                  <td colspan="1" rowspan="1" style="vertical-align: bottom;padding-left: 0px;padding-right: 0px;">
                    <p style="text-align: right; list-style-position: inside;margin-bottom: 0px; margin-top: 0px;"> $ </p>
                  </td>
                  <td colspan="1" rowspan="1" style="vertical-align: bottom;padding-left: 0px;padding-right: 0px;">
                    <p style="text-align: right; list-style-position: inside;margin-bottom: 0px; margin-top: 0px;"> 315,361 </p>
                  </td>
                </tr>
                <tr>
                  <td colspan="1" rowspan="1" style="vertical-align: bottom;padding-left: 20px;">Other current assets</td>
                  <td colspan="1" rowspan="1"><br>
                  </td>
                  <td colspan="1" rowspan="1" style="vertical-align: bottom;border-bottom: solid black 1pt;padding-left: 0px;padding-right: 0px;">
                    <p style="text-align: right; list-style-position: inside;margin-bottom: 0px; margin-top: 0px;"> &#160; </p>
                  </td>
                  <td colspan="1" rowspan="1" style="vertical-align: bottom;border-bottom: solid black 1pt;padding-left: 0px;padding-right: 0px;">
                    <p style="text-align: right; list-style-position: inside;margin-bottom: 0px; margin-top: 0px;"> 11,874 </p>
                  </td>
                  <td colspan="1" rowspan="1" style="vertical-align: bottom;padding-left: 0px;"><br>
                  </td>
                  <td colspan="1" rowspan="1" style="vertical-align: bottom;border-bottom: solid black 1pt;padding-left: 0px;padding-right: 0px;">
                    <p style="text-align: right; list-style-position: inside;margin-bottom: 0px; margin-top: 0px;"> &#160; </p>
                  </td>
                  <td colspan="1" rowspan="1" style="vertical-align: bottom;border-bottom: solid black 1pt;padding-left: 0px;padding-right: 0px;">
                    <p style="text-align: right; list-style-position: inside;margin-bottom: 0px; margin-top: 0px;"> 12,663 </p>
                  </td>
                </tr>
                <tr>
                  <td colspan="1" rowspan="1" style="vertical-align: bottom;padding-left: 20px;">Total current assets</td>
                  <td colspan="1" rowspan="1"><br>
                  </td>
                  <td colspan="1" rowspan="1" style="vertical-align: bottom;padding-left: 0px;padding-right: 0px;">
                    <p style="text-align: right; list-style-position: inside;margin-bottom: 0px; margin-top: 0px;"> &#160; </p>
                  </td>
                  <td colspan="1" rowspan="1" style="vertical-align: bottom;padding-left: 0px;padding-right: 0px;">
                    <p style="text-align: right; list-style-position: inside;margin-bottom: 0px; margin-top: 0px;"> 287,158 </p>
                  </td>
                  <td colspan="1" rowspan="1" style="vertical-align: bottom;padding-left: 0px;"><br>
                  </td>
                  <td colspan="1" rowspan="1" style="vertical-align: bottom;padding-left: 0px;padding-right: 0px;">
                    <p style="text-align: right; list-style-position: inside;margin-bottom: 0px; margin-top: 0px;"> &#160; </p>
                  </td>
                  <td colspan="1" rowspan="1" style="vertical-align: bottom;padding-left: 0px;padding-right: 0px;">
                    <p style="text-align: right; list-style-position: inside;margin-bottom: 0px; margin-top: 0px;"> 328,024 </p>
                  </td>
                </tr>
                <tr>
                  <td colspan="1" rowspan="1" style="vertical-align: top;padding-left: 20px;">Other assets</td>
                  <td colspan="1" rowspan="1"><br>
                  </td>
                  <td colspan="1" rowspan="1" style="vertical-align: bottom;border-bottom: solid black 1pt;padding-left: 0px;padding-right: 0px;">
                    <p style="text-align: right; list-style-position: inside;margin-bottom: 0px; margin-top: 0px;"> &#160; </p>
                  </td>
                  <td colspan="1" rowspan="1" style="vertical-align: bottom;border-bottom: solid black 1pt;padding-left: 0px;padding-right: 0px;">
                    <p style="text-align: right; list-style-position: inside;margin-bottom: 0px; margin-top: 0px;"> 27,563 </p>
                  </td>
                  <td colspan="1" rowspan="1" style="vertical-align: bottom;padding-left: 0px;"><br>
                  </td>
                  <td colspan="1" rowspan="1" style="vertical-align: bottom;border-bottom: solid black 1pt;padding-left: 0px;padding-right: 0px;">
                    <p style="text-align: right; list-style-position: inside;margin-bottom: 0px; margin-top: 0px;"> &#160; </p>
                  </td>
                  <td colspan="1" rowspan="1" style="vertical-align: bottom;border-bottom: solid black 1pt;padding-left: 0px;padding-right: 0px;">
                    <p style="text-align: right; list-style-position: inside;margin-bottom: 0px; margin-top: 0px;"> 30,144 </p>
                  </td>
                </tr>
                <tr>
                  <td colspan="1" rowspan="1" style="vertical-align: top;padding-left: 0px;">
                    <p style="margin-bottom: 0px; margin-top: 0px;"> Total assets </p>
                  </td>
                  <td colspan="1" rowspan="1"><br>
                  </td>
                  <td colspan="1" rowspan="1" style="vertical-align: bottom;border-bottom: double black 2.25pt;padding-left: 0px;padding-right: 0px;">
                    <p style="text-align: right; list-style-position: inside;margin-bottom: 0px; margin-top: 0px;"> $ </p>
                  </td>
                  <td colspan="1" rowspan="1" style="vertical-align: bottom;border-bottom: double black 2.25pt;padding-left: 0px;padding-right: 0px;">
                    <p style="text-align: right; list-style-position: inside;margin-bottom: 0px; margin-top: 0px;"> 314,721 </p>
                  </td>
                  <td colspan="1" rowspan="1" style="vertical-align: bottom;padding-left: 0px;"><br>
                  </td>
                  <td colspan="1" rowspan="1" style="vertical-align: bottom;border-bottom: double black 2.25pt;padding-left: 0px;padding-right: 0px;">
                    <p style="text-align: right; list-style-position: inside;margin-bottom: 0px; margin-top: 0px;"> $ </p>
                  </td>
                  <td colspan="1" rowspan="1" style="vertical-align: bottom;border-bottom: double black 2.25pt;padding-left: 0px;padding-right: 0px;">
                    <p style="text-align: right; list-style-position: inside;margin-bottom: 0px; margin-top: 0px;"> 358,168 </p>
                  </td>
                </tr>
                <tr>
                  <td colspan="1" rowspan="1" style="vertical-align: bottom;padding-left: 0px;"><br>
                  </td>
                  <td colspan="1" rowspan="1"><br>
                  </td>
                  <td rowspan="1" style="vertical-align: bottom;padding-left: 0px;" colspan="2"><br>
                  </td>
                  <td colspan="1" rowspan="1" style="vertical-align: bottom;padding-left: 0px;"><br>
                  </td>
                  <td rowspan="1" style="vertical-align: bottom;padding-left: 0px;" colspan="2">&#160;</td>
                </tr>
                <tr>
                  <td colspan="1" rowspan="1" style="vertical-align: bottom;padding-left: 0px;">
                    <p style="margin-bottom: 0px; margin-top: 0px;"> <b>Liabilities and Stockholders' Equity</b> </p>
                  </td>
                  <td colspan="1" rowspan="1"><br>
                  </td>
                  <td rowspan="1" style="vertical-align: bottom;padding-left: 0px;" colspan="2"><br>
                  </td>
                  <td colspan="1" rowspan="1" style="vertical-align: bottom;padding-left: 0px;"><br>
                  </td>
                  <td rowspan="1" style="vertical-align: bottom;padding-left: 0px;" colspan="2"><br>
                  </td>
                </tr>
                <tr>
                  <td colspan="1" rowspan="1" style="vertical-align: bottom;padding-left: 20px;">Current liabilities</td>
                  <td colspan="1" rowspan="1"><br>
                  </td>
                  <td colspan="1" rowspan="1" style="vertical-align: bottom;padding-left: 0px;padding-right: 0px;">
                    <p style="text-align: right; list-style-position: inside;margin-bottom: 0px; margin-top: 0px;"> $ </p>
                  </td>
                  <td colspan="1" rowspan="1" style="vertical-align: bottom;padding-left: 0px;padding-right: 0px;">
                    <p style="text-align: right; list-style-position: inside;margin-bottom: 0px; margin-top: 0px;"> 26,208 </p>
                  </td>
                  <td colspan="1" rowspan="1" style="vertical-align: bottom;padding-left: 0px;"><br>
                  </td>
                  <td colspan="1" rowspan="1" style="vertical-align: bottom;padding-left: 0px;padding-right: 0px;">
                    <p style="text-align: right; list-style-position: inside;margin-bottom: 0px; margin-top: 0px;"> $ </p>
                  </td>
                  <td colspan="1" rowspan="1" style="vertical-align: bottom;padding-left: 0px;padding-right: 0px;">
                    <p style="text-align: right; list-style-position: inside;margin-bottom: 0px; margin-top: 0px;"> 36,389 </p>
                  </td>
                </tr>
                <tr>
                  <td colspan="1" rowspan="1" style="vertical-align: top;padding-left: 20px;">Long-term liabilities</td>
                  <td colspan="1" rowspan="1"><br>
                  </td>
                  <td colspan="1" rowspan="1" style="vertical-align: bottom;padding-left: 0px;border-bottom: solid black 1pt;padding-right: 0px;">
                    <p style="text-align: right; list-style-position: inside;margin-bottom: 0px; margin-top: 0px;"> &#160; </p>
                  </td>
                  <td colspan="1" rowspan="1" style="vertical-align: bottom;padding-left: 0px;border-bottom: solid black 1pt;padding-right: 0px;">
                    <p style="text-align: right; list-style-position: inside;margin-bottom: 0px; margin-top: 0px;"> 59,860 </p>
                  </td>
                  <td colspan="1" rowspan="1" style="vertical-align: bottom;padding-left: 0px;"><br>
                  </td>
                  <td colspan="1" rowspan="1" style="vertical-align: bottom;padding-left: 0px;border-bottom: solid black 1pt;padding-right: 0px;">
                    <p style="text-align: right; list-style-position: inside;margin-bottom: 0px; margin-top: 0px;"> &#160; </p>
                  </td>
                  <td colspan="1" rowspan="1" style="vertical-align: bottom;padding-left: 0px;border-bottom: solid black 1pt;padding-right: 0px;">
                    <p style="text-align: right; list-style-position: inside;margin-bottom: 0px; margin-top: 0px;"> 61,544 </p>
                  </td>
                </tr>
                <tr>
                  <td colspan="1" rowspan="1" style="vertical-align: bottom;padding-left: 20px;">Total liabilities</td>
                  <td colspan="1" rowspan="1"><br>
                  </td>
                  <td colspan="1" rowspan="1" style="vertical-align: bottom;border-bottom: solid black 1pt;padding-left: 0px;padding-right: 0px;">
                    <p style="text-align: right; list-style-position: inside;margin-bottom: 0px; margin-top: 0px;"> &#160; </p>
                  </td>
                  <td colspan="1" rowspan="1" style="vertical-align: bottom;border-bottom: solid black 1pt;padding-left: 0px;padding-right: 0px;">
                    <p style="text-align: right; list-style-position: inside;margin-bottom: 0px; margin-top: 0px;"> 86,068 </p>
                  </td>
                  <td colspan="1" rowspan="1" style="vertical-align: bottom;padding-left: 0px;"><br>
                  </td>
                  <td colspan="1" rowspan="1" style="vertical-align: bottom;border-bottom: solid black 1pt;padding-left: 0px;padding-right: 0px;">
                    <p style="text-align: right; list-style-position: inside;margin-bottom: 0px; margin-top: 0px;"> &#160; </p>
                  </td>
                  <td colspan="1" rowspan="1" style="vertical-align: bottom;border-bottom: solid black 1pt;padding-left: 0px;padding-right: 0px;">
                    <p style="text-align: right; list-style-position: inside;margin-bottom: 0px; margin-top: 0px;"> 97,933 </p>
                  </td>
                </tr>
                <tr>
                  <td colspan="1" rowspan="1" style="vertical-align: bottom;padding-left: 20px;">Total stockholders' equity</td>
                  <td colspan="1" rowspan="1"><br>
                  </td>
                  <td colspan="1" rowspan="1" style="vertical-align: bottom;padding-left: 0px;border-bottom: solid black 1pt;padding-right: 0px;">
                    <p style="text-align: right; list-style-position: inside;margin-bottom: 0px; margin-top: 0px;"> &#160; </p>
                  </td>
                  <td colspan="1" rowspan="1" style="vertical-align: bottom;padding-left: 0px;border-bottom: solid black 1pt;padding-right: 0px;">
                    <p style="text-align: right; list-style-position: inside;margin-bottom: 0px; margin-top: 0px;"> 228,653 </p>
                  </td>
                  <td colspan="1" rowspan="1" style="vertical-align: bottom;padding-left: 0px;"><br>
                  </td>
                  <td colspan="1" rowspan="1" style="vertical-align: bottom;padding-left: 0px;border-bottom: solid black 1pt;padding-right: 0px;">
                    <p style="text-align: right; list-style-position: inside;margin-bottom: 0px; margin-top: 0px;"> &#160; </p>
                  </td>
                  <td colspan="1" rowspan="1" style="vertical-align: bottom;padding-left: 0px;border-bottom: solid black 1pt;padding-right: 0px;">
                    <p style="text-align: right; list-style-position: inside;margin-bottom: 0px; margin-top: 0px;"> 260,235 </p>
                  </td>
                </tr>
                <tr>
                  <td colspan="1" rowspan="1" style="vertical-align: top;padding-left: 0px;">
                    <p style="margin-bottom: 0px; margin-top: 0px;"> Total liabilities and stockholders' equity </p>
                  </td>
                  <td colspan="1" rowspan="1"><br>
                  </td>
                  <td colspan="1" rowspan="1" style="vertical-align: bottom;border-bottom: double black 2.25pt;padding-left: 0px;padding-right: 0px;">
                    <p style="text-align: right; list-style-position: inside;margin-bottom: 0px; margin-top: 0px;"> $ </p>
                  </td>
                  <td colspan="1" rowspan="1" style="vertical-align: bottom;border-bottom: double black 2.25pt;padding-left: 0px;padding-right: 0px;">
                    <p style="text-align: right; list-style-position: inside;margin-bottom: 0px; margin-top: 0px;"> 314,721 </p>
                  </td>
                  <td colspan="1" rowspan="1" style="vertical-align: bottom;padding-left: 0px;"><br>
                  </td>
                  <td colspan="1" rowspan="1" style="vertical-align: bottom;border-bottom: double black 2.25pt;padding-left: 0px;padding-right: 0px;">
                    <p style="text-align: right; list-style-position: inside;margin-bottom: 0px; margin-top: 0px;"> $ </p>
                  </td>
                  <td colspan="1" rowspan="1" style="vertical-align: bottom;border-bottom: double black 2.25pt;padding-left: 0px;padding-right: 0px;">
                    <p style="text-align: right; list-style-position: inside;margin-bottom: 0px; margin-top: 0px;"> 358,168 </p>
                  </td>
                </tr>
                <tr>
                  <td colspan="1" rowspan="1" style="vertical-align: bottom;padding-left: 0px;"><br>
                  </td>
                  <td colspan="1" rowspan="1"><br>
                  </td>
                  <td rowspan="1" style="vertical-align: bottom;padding-left: 0px;" colspan="2"><br>
                  </td>
                  <td colspan="1" rowspan="1" style="vertical-align: bottom;padding-left: 0px;"><br>
                  </td>
                  <td rowspan="1" style="vertical-align: bottom;padding-left: 0px;" colspan="2">&#160;</td>
                </tr>

            </table>
            <p> &#160; </p>
          </div>
          <div class="bw-release-contact">
            <h2 style="FONT-SIZE: 14pt;">Contacts</h2>
            <p> <b>Scholar Rock:</b> </p>
            <p> <b>I</b><b>nvestors &amp; Media </b><br>
              Rushmie Nofsinger <br>
              Scholar Rock <br>
              rnofsinger@scholarrock.com<br>
              ir@scholarrock.com<br>
              857-259-5573 </p>
          </div>
        </div>
      </div>
    </div>
    <div> <br>
    </div>
  </div>
</body>
</html>


  </div>

  </div>

          <script type="text/javascript">var s_CCSWebHostingAccount = "trcgscholarrock";</script>
        <script type="application/json" data-drupal-selector="drupal-settings-json">{"path":{"baseUrl":"\/","pathPrefix":"","currentPath":"node\/9441\/html","currentPathIsAdmin":false,"isFront":false,"currentLanguage":"en","themeUrl":"sites\/g\/files\/knoqqb56236\/themes\/site\/nir_pid2662"},"pluralDelimiter":"\u0003","suppressDeprecationErrors":true,"user":{"uid":0,"permissionsHash":"4506f7b957b4baf2488ee006e9b884f3b49293f46cfb6e03ffbb15fedba12da4"}}</script>
<script src="../../sites/g/files/knoqqb56236/files/js/js_D31miEwayYNfIODJWy2ump8i_gwklTzvOKq4eFgXiKw4996.js?scope=footer&amp;delta=0&amp;language=en&amp;theme=nir_pid2662&amp;include=eJyNjEEKgDAMBD8k9UkhTQMGSiJNRfp7ayuePHjK7jAblQIRnVdnAq8tsy_a2cnRpTKoVSH29YOF5w5__LiDkOlEqJhbN-b4bQGTRYaMh9L2Q9yLpQuf0kIl"></script>
<script src="../../../assets.adobedtm.com/898335afd880/c52ee8aa1e90/launch-5ef258dce664.min.js" crossorigin="anonymous" async integrity="sha384-9QSqHMB+yiy/V4i+d2Au+ydEWbBz4E9DqsE+oYKOnL+kj4XAZGYZxabd0P3OGHkf"></script>

  </body>
</html>
